
    
      An exploratory study to investigate the effects of the NK1 antagonist GW679769, 120 mg once
      daily for 4 days, on gastric accommodation, gastric emptying and gastric distension-induced
      perception and discomfort in adult male and female patients with functional dyspepsia, in a
      single-centre, placebo-controlled, double-blind, randomised, two-period crossover study
    
  